Anand Rathi initiates coverage on 4 agrochemical stocks with ‘buy’ rating
After a series of one-off events globally, the need to secure food supplies has become the top priority for every nation. Consequently, brokerage Anand Rathi believes that the structural growth story of the agrochemicals sector is intact, impelled by a) rising domestic demand; b) shrinking arable land (rising yields being the only way out); c) […]
These 5 Nifty stocks have most number of bullish estimates
The number of bullish estimates is the sum of strong buy and buy calls from analysts covered by the forecaster data set
Tech View: Nifty bulls show indecisiveness at peak. What traders should do on Tuesday
The positive chart pattern like higher tops and bottoms is intact on the daily chart and the Nifty is currently forming a new higher top of the sequence. A decisive move above 21,850 level is expected to nullify the present bearish effect and that could open more upside for the near term.
Saudi fund outpaces Singapore’s GIC with $31.6 billion splurge
The declines were led by GIC, which cut the amount of capital deployed by 46% to $19.9 billion and lost its spot as the world’s most active sovereign wealth fund for the first time in six years
Sona BLW Precision Forgings among 4 stocks that can rally up to 12% in short term
These stocks include Sona BLW Precision Forgings, Avanti Feeds, and Dabur
How much can Nifty go up in 2024 after record-shattering 2023? Let’s do some crystal-gazing
An ETMarkets poll of 23 analysts from Dalal Street shows that most analysts see Nifty ending at 23,000. In the base scenario, Axis Securities sees Nifty at 23,000 in December 2024 by predicting that earnings will grow at 14% CAGR over FY23-26
Nifty overvalued by 20%, says Kotak Equities, picks Britannia, NTPC for its All-Season portfolio
“As per our ‘Nifty fair value’ model, the index is now close to 20% overvalued. Thus, we do not anticipate a large upside to the index from this point. The most likely outcome for the index in the next 6-9 month period seems to be a time correction,” Kotak said in a note.
Tech Pick: Divi’s Labs gives a breakout from Inverse Head & Shoulder pattern; should you buy?
Short-term traders can look to buy the stock for a possible target above 4000-4300 levels in the 2 months, suggest experts
Hot Stocks: Brokerage view on Fortis Healthcare, Cello World, HPCL and Emami
Nomura maintained a buy rating on Fortis Healthcare but raised the target to Rs 475 from Rs 388 earlier. There are adequate levers in place to deliver margin expansion. The global investment bank sees the hospital segment’s EBITDA margin to improve to 20.2% in FY25 from 16.9% in FY23.
F&O stocks to buy today: Maruti, ITC among top 10 trading ideas
The Nifty future closed negative with losses of 0.37% at 21861 levels on Friday. India VIX was down by 4.21% from 15.14 to 14.50 levels. Volatility cooled off after steaming to higher zones and respected the bulls at higher zones.